Insider trade

Guardant Health (GH): Director sold ~$117K

Medina Manuel Hidalgo, Director at Guardant Health, sold ~$117K of Guardant Health shares.

~$117K
Approx. value · 2,165 sh @ $54.16
851
Holds after · shares reported
Traded
Sep 12, 2025
Filed
Sep 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 17, 2025Insider · 2 peopleInsiders: 2 sales (~$7K)
  2. Aug 19, 2025Insider · 2 peopleInsiders: 2 sales (~$8K)
  3. Aug 21, 2025InsiderOfficer sold ~$124K of GH shares in the open market
  4. Sep 2, 2025InsiderDirector sold ~$6.6K of GH shares in the open market
  5. Sep 9, 2025Insider · 1 personInsiders: 2 sales (~$17.8M)
  6. Sep 12, 2025 · this disclosureInsiderDirector sold ~$117K of GH shares in the open market

What came next

  1. Sep 12, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 12, 2025, the Board of Directors (the “Board”) of Guardant Health, Inc. (the “Company”) increased the number of directors on the Board to 11 and appointed Alex M. Azar II, former United States Secretary of Health and Human Services, as a Class III director of the Company, to be effective as of September 12, 2025.”
  2. Sep 17, 2025Insider · 2 peopleInsiders: 2 sales (~$8K)
  3. Oct 29, 2025Company filing · Form 8-K · ResultsReported its results
  4. Nov 4, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Guardant Health

For Guardant Health, OQRO holds 9 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GH page.

How this filing works

Explore the data

Common questions

Which Guardant Health (GH) insider traded, and how much?

Medina Manuel Hidalgo, Director at Guardant Health, sold ~$117K of Guardant Health shares. 2,165 shares at $54.16.

When did it happen, and when was it made public?

Traded: Sep 12, 2025. Filed: Sep 15, 2025. That is 3 days between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Guardant Health recently?

For Guardant Health, OQRO holds 9 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the GH page.

Does this mean GH stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Guardant Health

Everything OQRO holds on this company is on its GH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data